GHRS:NASDAQ, GH Research PLC

GHRS stock overview

GH Research PLC (GHRS:NASDAQ) closed at $17.53 on November 20, 2026, down 5.55% on the day. The stock trades 44.2% below its 52-week high of $31.44 and 45.6% above its 52-week low of $12.04. Over the past year, it gained 20.2%. GH Research PLC is part of the Health Care sector.

Key figures

Price
$17.53
Day change
-5.55%
Volume
298,833
Average volume
292,237
Market cap
1B+
52-week range
$12.04 – $31.44
50-day average
$21.56
200-day average
$21.75

Price action over the past year

In 252 trading sessions since November 20, 2025, GHRS closed higher on 126 days (50%). Its best day was January 7, 2026 (+27.12%) and its worst was January 8, 2026 (-13.37%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

GHRS news

About GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.

Similar stocks

Find more stocks like GHRS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.